RP Check
For Behaviour Support Practitioners

When the line is regulated, the page tells you why.

RP Check helps Behaviour Support Practitioners decide whether a medication or combination of medications constitutes a regulated chemical restraint under the NDIS framework — with jurisdictional and provider-context overlays. Every claim names the source it leaned on. Free. No accounts.

236 substances indexed · search by generic or brand name
§01 — Featured medications

A starter map

A curated cross-section of the most common medications encountered in BSP review. Every entry is also reachable by typing its name or any of its brand names above.

Atypical antipsychotic
Risperidone
Risperdal · Risperdal Consta · Rispa
Open page
Atypical antipsychotic
Quetiapine
Open page
SSRI
Sertraline
Open page
ADHD stimulant
Methylphenidate
Open page
Benzodiazepine
Diazepam
Open page
Melatonergic hypnotic
Melatonin
Open page
Magnesium supplement
Magnesium glycinate
Open page
Mood stabiliser / anticonvulsant
Sodium valproate
Open page
Source-driven
Every recommendation names its tier — TGA, Commonwealth, state, or provider context. You stay the messenger; the framework carries the demand.
No PII, ever
No participant identifiers. No BSP registration details on exports. No accounts to create. The tool is informational, not clinical advice.
Built for review
Pages render fully without JavaScript so they survive bad networks and old machines. Multi-substance reviews are coming next.